These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38928269)

  • 1. The Importance of the FUT2 rs602662 Polymorphism in the Risk of Cardiovascular Complications in Patients after Kidney Transplantation.
    Kotowski MJ; Ostrowski P; Sieńko J; Czerny B; Tejchman K; Machaliński B; Górska A; Mrozikiewicz AE; Bogacz A
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the variant rs602662 of FUT2 gene on anthropometric and metabolic parameters in a Caucasian obese population.
    de Luis D; Izaola O; Primo D
    Eur Rev Med Pharmacol Sci; 2022 Oct; 26(19):7169-7175. PubMed ID: 36263525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of TGFB1 and CTLA4 polymorphisms on calcineurin inhibitors dose and risk of acute rejection in renal transplantation.
    Bogacz A; Wolek M; Sieńko J; Czerny B; Machaliński B; Olbromski P; Kotowski M
    Sci Rep; 2021 Sep; 11(1):17531. PubMed ID: 34475433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FUT2 Genetic Variants and Reported Respiratory and Gastrointestinal Illnesses During Infancy.
    Barton SJ; Murray R; Lillycrop KA; Inskip HM; Harvey NC; Cooper C; Karnani N; Zolezzi IS; Sprenger N; Godfrey KM; Binia A
    J Infect Dis; 2019 Feb; 219(5):836-843. PubMed ID: 30376117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk profile after conversion from cyclosporine A to tacrolimus in stable renal transplant recipients.
    Baid-Agrawal S; Delmonico FL; Tolkoff-Rubin NE; Farrell M; Williams WW; Shih V; Auchincloss H; Cosimi AB; Pascual M
    Transplantation; 2004 Apr; 77(8):1199-202. PubMed ID: 15114085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of fucosyltransferase 2 gene polymorphism with the susceptibility to norovirus infection in Han Chinese population.
    Liu S; Chen H; Wen Z; Ouyang Y; Mei B; Li C
    J Med Virol; 2024 Aug; 96(8):e29848. PubMed ID: 39105389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fatty acid profile in phospholipids fraction with regard to blood pressure control in the kidney transplant patients].
    Wilusz M; Cieniawski D; Ignacak E; Bugajska J; Berska J; Bętkowska-Prokop A; Kużniewski M; Sułowicz W; Sztefko K
    Przegl Lek; 2016; 73(9):621-6. PubMed ID: 29688661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching from cyclosporine to tacrolimus in patients with chronic transplant dysfunction or cyclosporine-induced adverse events.
    Cantarovich D; Renou M; Megnigbeto A; Giral-Classe M; Hourmant M; Dantal J; Blancho G; Karam G; Soulillou JP
    Transplantation; 2005 Jan; 79(1):72-8. PubMed ID: 15714172
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Chen CT; Liao WY; Hsu CC; Hsueh KC; Yang SF; Teng YH; Yu YL
    Int J Med Sci; 2017; 14(9):885-890. PubMed ID: 28824326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of genetic variations for interleukin-10 (IL-10) on the efficacy of immunosuppressive therapy in patients after kidney transplantation.
    Bogacz A; Polaszewska A; Bartkowiak-Wieczorek J; Tejchman K; Dziewanowski K; Ostrowski M; Czerny B; Grześkowiak E; Sieńko M; Machaliński B; Sieńko J; Kotowski M
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107059. PubMed ID: 33039969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India.
    Agarwal SK; Bhowmik D; Mahajan S; Bagchi S
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27775825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New onset dyslipidemia after renal transplantation: is there a difference between tacrolimus and cyclosporine?
    Deleuze S; Garrigue V; Delmas S; Chong G; Swarcz I; Cristol JP; Mourad G
    Transplant Proc; 2006 Sep; 38(7):2311-3. PubMed ID: 16980075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients.
    Sommerer C; Suwelack B; Dragun D; Schenker P; Hauser IA; Witzke O; Hugo C; Kamar N; Merville P; Junge M; Thaiss F; Nashan B;
    Kidney Int; 2019 Jul; 96(1):231-244. PubMed ID: 31027892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of the effects of C2-cyclosporine and C0-tacrolimus on renal function and cardiovascular risk factors in kidney transplant recipients.
    Kim SJ; Prasad GV; Huang M; Nash MM; Famure O; Park J; Thenganatt MA; Chowdhury N; Cole EH; Fenton SS; Cattran DC; Zaltzman JS; Cardella CJ
    Transplantation; 2006 Oct; 82(7):924-30. PubMed ID: 17038908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus.
    Taylor DO; Barr ML; Radovancevic B; Renlund DG; Mentzer RM; Smart FW; Tolman DE; Frazier OH; Young JB; VanVeldhuisen P
    J Heart Lung Transplant; 1999 Apr; 18(4):336-45. PubMed ID: 10226898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinations of FUT2 gene polymorphisms and environmental factors are associated with oral cancer risk.
    Su KJ; Ho CC; Lin CW; Chen MK; Su SC; Yu YL; Yang SF
    Tumour Biol; 2016 May; 37(5):6647-52. PubMed ID: 26646561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma homocysteine levels in renal transplanted patients on cyclosporine or tacrolimus therapy: effect of treatment with folic acid.
    Fernández-Miranda C; Gómez P; Díaz-Rubio P; Estenoz J; Carillo JL; Andrés A; Morales JM
    Clin Transplant; 2000 Apr; 14(2):110-4. PubMed ID: 10770414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of CYP3A5 and CYP3A4 gene polymorphisms on dose requirement of calcineurin inhibitors, cyclosporine and tacrolimus, in renal allograft recipients of North India.
    Singh R; Srivastava A; Kapoor R; K Sharma R; D Mittal R
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Aug; 380(2):169-77. PubMed ID: 19343327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.